Clinical Trial Update: UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial sponsored by the University of Alabama at Birmingham evaluating UAB 2419-CD34 selection using the CliniMACS Prodigy system for AML and AL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Lymphoid Malignancies
• Myelodysplastic Syndromes
• Myelofibrosis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: AML, ALL | Phase 1 | Status: RECRUITING